OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells
Yingxin Yu, Bart R. Blokhuis, Mara A. P. Diks, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Role of Mast Cells in Shaping the Tumor Microenvironment
Daniel Elieh Ali Komi, Frank A. Redegeld
Clinical Reviews in Allergy & Immunology (2019) Vol. 58, Iss. 3, pp. 313-325
Open Access | Times Cited: 295

Function of Macrophages in Disease: Current Understanding on Molecular Mechanisms
Chunye Zhang, Ming Yang, Aaron C. Ericsson
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 134

Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia
Hardikkumar Jetani, Almudena Navarro‐Bailón, Marius Maucher, et al.
Blood (2021) Vol. 138, Iss. 19, pp. 1830-1842
Open Access | Times Cited: 68

Selected recent advances in understanding the role of human mast cells in health and disease
Francesca Levi‐Schaffer, Bernhard F. Gibbs, Jenny Hallgren, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 6, pp. 1833-1844
Closed Access | Times Cited: 39

Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis
Xiaoxin Liu, Xinyu Li, Haotian Wei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31

Eosinophil and mast cell Siglecs: From biology to drug target
Jeremy A. O’Sullivan, Alan T. Chang, Bradford A. Youngblood, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 1, pp. 73-81
Open Access | Times Cited: 57

Novel Strategies to Target Mast Cells in Disease
Aida Paivandy, Gunnar Pejler
Journal of Innate Immunity (2021) Vol. 13, Iss. 3, pp. 131-147
Open Access | Times Cited: 52

The intriguing roles of Siglec family members in the tumor microenvironment
Kui-Ying Jiang, Lili Qi, Fubiao Kang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 28

Siglec-6 mediates the uptake of extracellular vesicles through a noncanonical glycolipid binding pocket
Edward N. Schmidt, Dimitra Lamprinaki, Kelli A. McCord, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18

Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments
Elena Gianchecchi, Andrea Arena, Alessandra Fierabracci
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5774-5774
Open Access | Times Cited: 40

The (Sialyl) Tn antigen: Contributions to immunosuppression in gastrointestinal cancers
Christabelle Rajesh, Prakash Radhakrishnan
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 13

Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells
Piper A. Robida, Clayton H. Rische, Netali Ben-Baruch Morgenstern, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1138-1138
Open Access | Times Cited: 22

Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia
Christopher Schorr, Fabiana Perna
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22

Siglecs in allergy and asthma
Bruce S. Bochner, Jeremy A. O’Sullivan, Alan T. Chang, et al.
Molecular Aspects of Medicine (2022) Vol. 90, pp. 101104-101104
Open Access | Times Cited: 19

Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer
Ramya Ephraim, Jack Feehan, Sarah Fraser, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6131-6131
Open Access | Times Cited: 18

Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils
Dubravka Smiljkovic, Harald Herrmann, Irina Sadovnik, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 1, pp. 202-211
Open Access | Times Cited: 17

Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer
Dorothea Plundrich, Sophia Chikhladze, Stefan Fichtner‐Feigl, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2782-2782
Open Access | Times Cited: 16

Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases
Jeremy A. O’Sullivan, Bradford A. Youngblood, Robert P. Schleimer, et al.
Seminars in Immunology (2023) Vol. 69, pp. 101799-101799
Open Access | Times Cited: 10

Research Advances in Mast Cell Biology and Their Translation Into Novel Therapies for Anaphylaxis
Melanie C. Dispenza, Dean D. Metcalfe, Ana Olivera
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 7, pp. 2032-2042
Open Access | Times Cited: 8

Targeting the FcεRI Pathway as a Potential Strategy to Prevent Food-Induced Anaphylaxis
Melanie C. Dispenza, Bruce S. Bochner, Donald W. MacGlashan
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 23

Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia
Damián Kovalovsky, Jeong Heon Yoon, Matthew G. Cyr, et al.
Leukemia (2021) Vol. 35, Iss. 9, pp. 2581-2591
Open Access | Times Cited: 18

Killer Immunoglobulin-Like Receptor 2DL4 (CD158d) Regulates Human Mast Cells both Positively and Negatively: Possible Roles in Pregnancy and Cancer Metastasis
Tatsuki R. Kataoka, Chiyuki Ueshima, Masahiro Hirata, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 954-954
Open Access | Times Cited: 19

Tumor Derived SIGLEC Family Genes May Play Roles in Tumor Genesis, Progression, and Immune Microenvironment Regulation
Zheng Chen, Mincheng Yu, Lei Guo, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 19

Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid Leukemia
Marius Maucher, Micha Srour, Sophia Danhof, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6157-6157
Open Access | Times Cited: 17

Integrative Analysis of the Expression of SIGLEC Family Members in Lung Adenocarcinoma via Data Mining
Haiyan Zhang, Yong-Fei Xie, Zhi Hu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 14

Page 1 - Next Page

Scroll to top